Table 4.
Distribution of obesity, insulin resistance, and metabolic syndrome among euthyroid and subclinical hypothyroid participants.
| N (%) | ||||
|---|---|---|---|---|
| Euthyroidism | Subclinical hypothyroidism | Total (N) | P | |
| Weight groups | ||||
| Under weight | 20 (1.9) | 1 (2.04) | 21 | 0.199 |
| Normal | 406 (38.8) | 19 (38.7) | 431 | |
| Over weight | 343 (32.8) | 16 (32.6) | 361 | |
| Obesity | 275 (26.3) | 13 (26.5) | 292 | |
| Total | 1044 (100) | 49 (100) | 1105 | |
| HOMA-IR groups | ||||
| Normal | 661 (79.6) | 31 (88.5) | 700 | * |
| Border line high | 102 (12.2) | 2 (5.7) | 104 | |
| Insulin resistance | 67 (8.07%) | 2 (5.7) | 70 | |
| Total | 830 (100) | 35 (100) | 874 | |
| WC groups | ||||
| Normal | 422 (40.2) | 18 (36.7) | 440 | 0.001 |
| Central obesity | 336 (32.1) | 17 (34.7) | 353 | |
| Metabolic syndrome (≥2 risk factors) | 291 (27.7) | 14 (28.6) | 305 | |
| Total | 1049 (100) | 49 (100) | 1098 | |
Bold value significance 0.001.
HOMA-IR, Homeostatic Model Assessment for Insulin Resistance; WC, waist circumference.
*
No statistical test was conducted.